CD8+ CTLs can recognize abnormal cells, such as tumor cells by cooperating with helper T1 cells (Th1) and mediate antitumor immune responses by releasing perforin, granzyme, and TNF-α to damage tumor cells (48). Here, PRF1 is linked to neoplasm.